ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,959Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 2343

$1.61M Total Retail Price of All Prescriptions

Rank: 17 out of 2343

606 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 606 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 606 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 27,320 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 1,488 1,416 1 6
OMEPRAZOLE 958 838 2 4
JANTOVEN 858 849 3 81
LISINOPRIL 834 743 4 3
WARFARIN SODIUM 741 725 5 8
SIMVASTATIN 735 657 6 1
DONEPEZIL HCL 673 631 7 21
LEVOTHYROXINE SODIUM 624 573 8 2
METOPROLOL TARTRATE 583 486 9 7
SERTRALINE HCL 526 433 10 20
CITALOPRAM HBR 518 443 11 17
AMLODIPINE BESYLATE 492 462 12 5
OXYCODONE-ACETAMINOPHEN 484 385 S2 13 49
NAMENDA 473 433 14 36
KLOR-CON M20 450 429 15 44
PRAVASTATIN SODIUM 368 328 16 15
RISPERIDONE 330 286 17 61
MIRTAZAPINE 328 323 18 41
METFORMIN HCL 318 274 19 9
GABAPENTIN 318 264 19 16
TAMSULOSIN HCL 294 278 21 29
AZITHROMYCIN 292 253 22 39
HYDROCODONE-ACETAMINOPHEN 285 266 S3 23 13
IPRATROPIUM-ALBUTEROL 284 259 24 99
POTASSIUM CHLORIDE 283 254 25 18
ISOSORBIDE MONONITRATE ER 278 271 26 32
LANTUS 277 222 27 51
METOPROLOL SUCCINATE 275 264 28 14
NYSTATIN-TRIAMCINOLONE 274 254 29 249
ATORVASTATIN CALCIUM 269 216 30 10
CLOPIDOGREL 269 230 30 26
METOLAZONE 252 244 32 173
MELOXICAM 244 203 33 68
DIVALPROEX SODIUM 242 223 34 105
PANTOPRAZOLE SODIUM 240 230 35 22
ALENDRONATE SODIUM 232 232 36 28
HYDRALAZINE HCL 224 185 37 92
TRAMADOL HCL 220 164 38 25
CARVEDILOL 217 209 39 27
OXYBUTYNIN CHLORIDE ER 215 197 40 149
SPIRONOLACTONE 200 175 41 65
ALLOPURINOL 198 176 42 31
ATENOLOL 193 172 43 12
LANTUS SOLOSTAR 190 155 44 101
HYDROCHLOROTHIAZIDE 182 178 45 11
CEPHALEXIN 182 160 45 111
ROPINIROLE HCL 176 141 47 124
CLONIDINE HCL 168 147 48 70
CIPROFLOXACIN HCL 164 143 49 72
CARBIDOPA-LEVODOPA 162 151 50 85
ADVAIR DISKUS 155 135 51 34
PLAVIX 153 133 52 38
PHENYTOIN SODIUM EXTENDED 153 129 52 152
DILANTIN 147 133 54 327
FENTANYL 133 72 S2 55 69
NEXIUM 132 96 56 33
DIGOXIN 131 130 57 35
HUMALOG 127 93 58 131
OLANZAPINE 127 118 58 121
NOVOLIN R 126 103 60 227
ARMOUR THYROID 126 102 R 60 470
ESCITALOPRAM OXALATE 122 100 62 55
AMOXICILLIN 117 87 63 118
PREDNISONE 117 103 63 37
LEVETIRACETAM 117 113 63 104
ALBUTEROL SULFATE 115 81 66 126
GLIPIZIDE ER 114 109 67 115
TRAZODONE HCL 112 94 68 53
HUMULIN R 112 96 68 269
PEN NEEDLE 110 92 70 119
FINASTERIDE 109 99 71 80
CYMBALTA 108 93 72 74
ENALAPRIL MALEATE 107 107 73 58
VENLAFAXINE HCL ER 107 102 73 87
LAMOTRIGINE 106 81 75 194
SINGULAIR 105 99 76 100
RANITIDINE HCL 103 86 77 43
PAROXETINE HCL 102 87 78 66
LEVOFLOXACIN 102 86 78 106
CRESTOR 100 84 80 30
DOXYCYCLINE HYCLATE 100 92 80 180
MEGESTROL ACETATE 100 96 R 80 246
POLYETHYLENE GLYCOL 3350 99 97 83 54
IPRATROPIUM BROMIDE 97 95 84 192
JANUVIA 97 95 84 50
GLIPIZIDE XL 93 81 86 84
DIOVAN 89 87 87 23
INSULIN SYRINGE 88 67 88 102
SULFAMETHOXAZOLE-TRIMETHOPRIM 88 76 88 120
OXYCODONE HCL 85 72 S2 90 67
HALOPERIDOL 83 59 91 229
METOCLOPRAMIDE HCL 82 63 92 168
LOSARTAN POTASSIUM 81 80 93 19
AMIODARONE HCL 80 76 94 158
QUETIAPINE FUMARATE 76 56 95 77
AVELOX 74 72 96 360
GLIPIZIDE 73 73 97 56
LIDODERM 72 72 98 130
ABILIFY 72 59 98 159
DILTIAZEM 24HR ER 70 70 100 76
TRICOR 69 52 101 96
NOVOLIN 70-30 68 68 102 268
CARBAMAZEPINE 66 50 103 206
TRIAMCINOLONE ACETONIDE 66 55 103 137
KLOR-CON M10 65 65 105 107
EXELON 63 63 106 129
DETROL LA 62 62 107 150
LATANOPROST 62 62 107 200
FAMOTIDINE 61 40 109 60
OXYCONTIN 61 36 S2 109 138
GLIMEPIRIDE 59 56 111 45
LIPITOR 59 59 111 78
ACETAZOLAMIDE 59 45 111 486
AVODART 59 59 111 165
SPIRIVA 59 52 111 48
NOVOLOG 58 52 116 110
LIDOCAINE HCL 57 52 117 378
LABETALOL HCL 57 47 117 153
KENALOG-40 56 39 119 553
DILTIAZEM 24HR CD 55 52 120 83
FLUOXETINE HCL 55 47 120 82
CALCIUM ACETATE 54 27 122 291
BACLOFEN 52 18 123 161
TERAZOSIN HCL 50 50 124 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.